Medical technology from a Cambridge startup is set to help Big Pharma companies develop more effective cardiovascular drugs.
Eagle, the Cambridge UK bioinformatics software and services business, has made several key appointments as it rolls out major initiatives in genomics research.
People who suffer from colour blindness are expected to benefit from the trial of new UK technology.
A Cambridge company whose bug-busting technology is cleaning up hospitals and other medical environments across the UK and worldwide has revealed its fifth profit upgrade this financial year following a strong second half performance.
Horizon CombinatoRx, a division of Cambridge UK medical technology business Horizon Discovery, has been contracted by Otsuka Pharmaceutical Development and Commercialization (OPDC) to perform in vitro cell line screening of certain OPDC development candidates.
A Cambridge UK telemedicine company whose technology helps vets around the world diagnose and treat animals faster and more effectively is investing in global growth.
Medical technology front runner Horizon Discovery has hoisted interim sales 36 per cent year-on-year and is scaling up fast in all its global target territories from its Cambridge UK headquarters.
Cambridge technology innovator Sagentia and a UK partner are working to develop a groundbreaking diagnostic for pre-natal screening.
A Cambridge UK collaboration with a US pharmaceutical partner is making significant progress with a new cough cold remedy.
Medical technology enabler Abcam says it will beat profit expectations for the year to June 30.
Cambridge UK cancer technology pioneer Endomagnetics is targeting Australasia with its breast cancer sensors after reporting “huge” interest from surgeons in the territory.
IXICO, the UK brain health technology business with powerful Cambridge links, has accelerated its growth strategy after building a strong platform on new contract wins, grant income and a healthy pipeline.
AstraZeneca today revealed the proposed designs for a stunning new global R & D Centre and corporate headquarters in Cambridge UK with eco-friendly energy management at its heart.
The Genome Analysis Centre (TGAC) in Norfolk has become one of the first research Institutes in the UK to use the pioneering genome mapping Irys System technology by BioNano Genomics, adding to its existing state-of-the-art Next Generation Sequencing (NGS) suite at the centre.
Cambridge UK technology is in the front line of a global fight against diabetes.
Patients suffering the life-threatening effects of a blocked artery in the brain now have the benefit of pioneering interventional treatments thanks to collaboration between Southend University Hospital NHS Foundation Trust and Anglia Ruskin University.
- Cambridge answers antibiotics call to arms
- Abzena raises £22.7 million for AIM float
- IXICO opens Pennsylvania office
- Horizon Discovery licenses gene technology from Stanford
- Cambridge key as MRC and AstraZeneca boost drive for new medicines
- Cambridge Cognition revenues running 25 per cent ahead
- Japan patent coup for Sareum invention
- TSB funds Isogenica-Imperial DNA initiative
- New chairman at Abcam as Redmond stands down
- $12m US asthma deal for Vectura and more to come
- Abcodia keen to license heart disease biomarker
- UK climbs aboard Cambs care card revolution
- Cambridge technology fights potential drug damage to nervous system
- Endomagnetics completes acquisition of ACT portfolio
- Vectura milestones for respiratory drug may hit $45 million
- TTP LabTech revenues soar 43 per cent
Page 1 of 61